Hector M. Garcia-Garcia 2012-08-08
Latest Clinical Performance Evidence of Bioabsorbable Coronary Stents
Alexandre Abizaid 2012-08-08
Contemporary Strategies for the Prevention and Management of Stent Thrombosis
Julio Lopez Cuellar 2012-08-08
Post Stent Antithrombotic Management of the Patient on Oral Anticoagulation: Disentangling a Trouble-prone Situation
Mario A. Benavides 2012-08-08
Update on the Current Status of the Enduring Drug Eluting Stents.
Alexandre Abizaid 2012-08-08
Stents farmacológicos de 2da generación, resultados a 2 años en pacientes “reales”
Título Original: Clinical Outcome Following Stringent Discontinuation of Dual Anti-Platelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: Two-Year Follow-up of the Randomized TWENTE Trial. Referencia: Keneth T, Hanim S, et al. J Am Coll Cardiol 2013. Article in press. En los últimos años han<a href="https://solaci.org/2015/06/01/stents-farmacologicos-de-2da-generacion-resultados-a-2-anos-en-pacientes-reales/" title="Read more" >...</a>
Estudio Randomizado sobre Stent Liberador de Sirolimus con polímero bioabsorvible: Resultados del protocolo DESSOLVE II
Título Original: Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial. Referencia: Wijns W EuroIntervention 2015 Apr 22;10(12):1383-90. Estudio multicéntrico y randomizado, que enroló en 26 centros un total de 184 pacientes bajo la modalidad 2:1 (stent liberador de sirolimus con polímero bioabsorvible (SLSPA) [n=123] versus stent liberador de<a href="https://solaci.org/2015/05/08/estudio-randomizado-sobre-stent-liberador-de-sirolimus-con-polimero-bioabsorvible-resultados-del-protocolo-dessolve-ii/" title="Read more" >...</a>